Mgenplus Co. Ltd. (032790) - Net Assets
Based on the latest financial reports, Mgenplus Co. Ltd. (032790) has net assets worth ₩28.72 Billion KRW (≈ $19.46 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩55.61 Billion ≈ $37.69 Million USD) and total liabilities (₩26.89 Billion ≈ $18.22 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 032790 asset base for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩28.72 Billion |
| % of Total Assets | 51.64% |
| Annual Growth Rate | 2.41% |
| 5-Year Change | 83.24% |
| 10-Year Change | 138.6% |
| Growth Volatility | 53.58 |
Mgenplus Co. Ltd. - Net Assets Trend (2006–2025)
This chart illustrates how Mgenplus Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Mgenplus Co. Ltd. to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Mgenplus Co. Ltd. (2006–2025)
The table below shows the annual net assets of Mgenplus Co. Ltd. from 2006 to 2025. For live valuation and market cap data, see Mgenplus Co. Ltd. market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩33.69 Billion ≈ $22.83 Million |
-23.65% |
| 2024-12-31 | ₩44.12 Billion ≈ $29.90 Million |
+19.29% |
| 2023-12-31 | ₩36.99 Billion ≈ $25.07 Million |
-20.43% |
| 2022-12-31 | ₩46.48 Billion ≈ $31.50 Million |
+152.86% |
| 2018-12-31 | ₩18.38 Billion ≈ $12.46 Million |
-18.43% |
| 2017-12-31 | ₩22.54 Billion ≈ $15.27 Million |
+96.36% |
| 2016-12-31 | ₩11.48 Billion ≈ $7.78 Million |
+33.61% |
| 2015-12-31 | ₩8.59 Billion ≈ $5.82 Million |
-15.30% |
| 2014-12-31 | ₩10.14 Billion ≈ $6.87 Million |
-28.17% |
| 2013-12-31 | ₩14.12 Billion ≈ $9.57 Million |
-24.86% |
| 2012-12-31 | ₩18.79 Billion ≈ $12.73 Million |
-34.83% |
| 2011-12-31 | ₩28.83 Billion ≈ $19.54 Million |
+62.14% |
| 2008-12-31 | ₩17.78 Billion ≈ $12.05 Million |
+2.31% |
| 2007-12-31 | ₩17.38 Billion ≈ $11.78 Million |
-18.89% |
| 2006-12-31 | ₩21.42 Billion ≈ $14.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Mgenplus Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 363.1% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩57.44 Billion | 170.02% |
| Total Equity | ₩33.78 Billion | 100.00% |
Mgenplus Co. Ltd. Competitors by Market Cap
The table below lists competitors of Mgenplus Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Coats Group PLC
LSE:COA
|
$17.49 Million |
|
Clime Investment Management Ltd
AU:CIW
|
$17.49 Million |
|
NORTHERN FREEGOLD
F:8N6
|
$17.49 Million |
|
Komputronik S.A.
WAR:KOM
|
$17.49 Million |
|
Scidev Ltd
AU:SDV
|
$17.48 Million |
|
Bright Scholar Education Holdings Ltd Class A
NYSE:BEDU
|
$17.48 Million |
|
Daedong Steel Co. Ltd
KQ:048470
|
$17.48 Million |
|
Memphasys Ltd
AU:MEM
|
$17.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mgenplus Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 44,170,934,490 to 33,784,429,810, a change of -10,386,504,680 (-23.5%).
- Net loss of 16,282,955,310 reduced equity.
- New share issuances of 1,003,971,480 increased equity.
- Other factors increased equity by 4,892,479,150.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-16.28 Billion | -48.2% |
| Share Issuances | ₩1.00 Billion | +2.97% |
| Other Changes | ₩4.89 Billion | +14.48% |
| Total Change | ₩- | -23.51% |
Book Value vs Market Value Analysis
This analysis compares Mgenplus Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.76x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.36x to 0.76x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | ₩2789.51 | ₩1005.00 | x |
| 2023-12-31 | ₩1789.68 | ₩1005.00 | x |
| 2024-12-31 | ₩2036.08 | ₩1005.00 | x |
| 2025-12-31 | ₩1315.59 | ₩1005.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mgenplus Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -48.20%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -56.95%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.77x
- Recent ROE (-48.20%) is below the historical average (-35.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 10.29% | 1.40% | 3.54x | 2.07x | ₩62.23 Million |
| 2014 | -52.35% | -7.45% | 2.30x | 3.06x | ₩-6.55 Billion |
| 2015 | -119.78% | -17.58% | 2.15x | 3.17x | ₩-11.16 Billion |
| 2016 | -51.51% | -11.54% | 1.74x | 2.56x | ₩-7.07 Billion |
| 2017 | -9.92% | -4.17% | 1.49x | 1.60x | ₩-4.49 Billion |
| 2018 | -31.33% | -11.61% | 0.95x | 2.83x | ₩-7.60 Billion |
| 2022 | -0.94% | -0.40% | 1.45x | 1.63x | ₩-5.08 Billion |
| 2023 | -56.89% | -102.72% | 0.31x | 1.80x | ₩-25.00 Billion |
| 2024 | 7.00% | 8.97% | 0.48x | 1.62x | ₩-1.32 Billion |
| 2025 | -48.20% | -56.95% | 0.48x | 1.77x | ₩-19.66 Billion |
Industry Comparison
This section compares Mgenplus Co. Ltd.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $362,755,228,058
- Average return on equity (ROE) among peers: -3.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mgenplus Co. Ltd. (032790) | ₩28.72 Billion | 10.29% | 0.94x | $17.49 Million |
| ORIENTBIO Inc. (002630) | $61.77 Billion | 0.00% | 0.69x | $78.75 Million |
| Green Cross (005250) | $895.76 Billion | 3.06% | 4.14x | $293.85 Million |
| Green Cross Holdings Preference Shares (005257) | $1.91 Trillion | 2.89% | 0.83x | $2.53 Million |
| Pharmicell (005690) | $101.58 Billion | -17.37% | 0.34x | $454.62 Million |
| GeneOne Life Science Inc (011000) | $98.51 Billion | -18.93% | 0.39x | $164.07 Million |
| HLB Co. Ltd (028300) | $88.75 Billion | -14.89% | 1.10x | $2.70 Billion |
| Daesung Microbiological Labs. Co. Ltd (036480) | $35.09 Billion | 8.12% | 0.45x | $16.76 Million |
| Seoulin Bioscience Co.Ltd (038070) | $53.72 Billion | 4.89% | 0.32x | $26.32 Million |
| Hyundai Bioscience Co. Ltd (048410) | $18.90 Billion | 0.00% | 0.70x | $426.30 Million |
About Mgenplus Co. Ltd.
Mgen Solutions Co., Ltd. engages in broadband communication network construction business. The company offers electricity, bio business and fire facility construction business, firefighting equipment and construction; printer developer; manufacturing and supply of electrical and electronic products such as transformers and inductors; artificial intelligence video analysis solution; printer develo… Read more